| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 703467 | Null | 0.0244632509325736 | 0.42134538 |
| NSC 711745 | Null | 0.0244632509325736 | 0.17444285 |
| NSC 715755 | Null | 0.0244632509325736 | 0.27229165 |
| NSC 726262 | 1,1'-{[(bispropane-1,N-diyl)piperzine]dioxy}bis[(11aS)-7-met hoxy-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepi n-5-one | 0.0244632509325736 | 0.32083741 |
| NSC 754328 | Null | 0.0244632509325736 | 0.1921639 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.0244632509325736 | 0.55732824 |
| NSC 79563 | 1,3-bis(4-chlorobenzyl)-2-(phenanthren-9-yl)hexahydropyrimidine | 0.0244632509325736 | 0.36164834 |
| NSC 96996 | B 169 | 0.0244632509325736 | 0.53470173 |
| NSC 639511 | Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-methoxy- phenyl)methylene]-, hydrochloride | 0.0244718705444135 | 0.36023438 |
| NSC 666667 | Null | 0.0244718705444135 | 0.41045622 |